On the second anniversary of the coronavirus pandemic, more than 130 world leaders, economists, humanitarians, scientists and other prominent figures are calling for an end to vaccine monopolies, urging action to rapidly vaccinate low- and middle-income countries.
“Sadly, despite what some leaders in wealthy countries would like us to believe, the pandemic is not over,” the letter says, “but it is within our grasp to end it.”
Banda said that “this pandemic is far from over in Africa and across the world,” with thousands of avoidable deaths happening each day. “We must recapture the spirit of solidarity to end the suffering and create a better future. That starts now with ending these callous pharmaceutical monopolies on covid-19 vaccines, so Africa and the world can tackle this crisis and the next,” she added.
The letter’s signatories criticized Germany, Switzerland, Britain and the European Union for continuing “to block the lifting of intellectual property rules which would enable the redistribution and scale-up of COVID-19 vaccine, test and treatment manufacturing in the global south.”
As most developed countries reopen while some developing nations continue to sustain coronavirus restrictions, a new global divide is emerging. “In some countries, high vaccine coverage, combined with the lower severity of omicron, is driving a false narrative that the pandemic is over,” WHO Director General Tedros Adhanom Ghebreyesus said Feb. 14 at a covid-19 Global Action Meeting. “At the same time, low vaccine coverage and low testing rates in other countries are creating the ideal conditions for new variants to emerge.”
Covax, a mechanism created at the beginning of the pandemic to supply low-income countries with the coronavirus vaccine, faced many obstacles in fulfilling its mission, mostly logistical hurdles and a supply shortage. The initiative, co-led by the WHO, the Coalition for Epidemic Preparedness Innovations (CEPI) and Gavi, was able to ramp up distribution toward the end of last year.
More than 1 billion doses were delivered through Covax as of Jan. 17, according to Gavi.